Spantide I (trifluoroacetate salt) 25 mg | ≥98% Cayman Chemical A peptide antagonist of the NK1 receptor More Information Supplier Page × Spantide I (trifluoroacetate salt)
Spantide I (trifluoroacetate salt) 10 mg | ≥98% Cayman Chemical A peptide antagonist of the NK1 receptor More Information Supplier Page × Spantide I (trifluoroacetate salt)
5-Hydroxypropafenone (hydrochloride) 5 mg | ≥98% Cayman Chemical An active metabolite of propafenone More Information Supplier Page × 5-Hydroxypropafenone (hydrochloride)
5-Hydroxypropafenone (hydrochloride) 1 mg | ≥98% Cayman Chemical An active metabolite of propafenone More Information Supplier Page × 5-Hydroxypropafenone (hydrochloride)
1-Methylnicotinamide (iodide) 500 mg | ≥95% Cayman Chemical An active metabolite of nicotinamide More Information Supplier Page × 1-Methylnicotinamide (iodide)
1-Methylnicotinamide (iodide) 250 mg | ≥95% Cayman Chemical An active metabolite of nicotinamide More Information Supplier Page × 1-Methylnicotinamide (iodide)
1-Methylnicotinamide (iodide) 100 mg | ≥95% Cayman Chemical An active metabolite of nicotinamide More Information Supplier Page × 1-Methylnicotinamide (iodide)
1-Methylnicotinamide (iodide) 1 g | ≥95% Cayman Chemical An active metabolite of nicotinamide More Information Supplier Page × 1-Methylnicotinamide (iodide)
VU0542270 50 mg | ≥98% Cayman Chemical A SUR2B/Kir6.1 inhibitor More Information Supplier Page × VU0542270
VU0542270 5 mg | ≥98% Cayman Chemical A SUR2B/Kir6.1 inhibitor More Information Supplier Page × VU0542270
